130th MAINE LEGISLATURE
		LD 1115		LR 1215(01)
	An Act To Improve Access to HIV Prevention Medications
	Preliminary Fiscal Impact Statement for Original Bill
	Sponsor: Sen. Sanborn of Cumberland
	Committee: Health Coverage, Insurance and Financial Services
	Fiscal Note Required: Yes
Preliminary Fiscal Impact Statement
			FY 2021-22	FY 2022-23	Projections  FY 2023-24	Projections  FY 2024-25
Appropriations/Allocations
	Other Special Revenue Funds		$43,839	$55,675	$58,640	$61,783
Transfers
	Other Special Revenue Funds		$0	$0	$0	$0
Fiscal Detail and Notes
	The Department of Professional and Financial Regulation will require Other Special Revenue Funds allocations totaling $43,839 in fiscal year 2021-22 and $55,675 in fiscal year 2022-23 to implement the requirements of this legislation within the Office of Professional and Occupational Licensing, Maine Board of Pharmacy.
	Of this amount, the Licensing and Enforcement program will require Other Special Revenue Funds allocations of $41,110 in fiscal year 2021-22 and $52,328  in fiscal year 2022-23 to establish one half-time Regulatory Health Compliance position and related All Other costs to manage the anticipated increase in workload associated with the regulation of pharmacists authority to dispense HIV prevention drugs.  Additionally, the Administrative Services Division will require Other Special Revenue Funds allocations of $2,729 in fiscal year 2021-22 and $3,347 in fiscal year 2022-23 for technology-related costs associated with establishing the Regulatory Health Compliance position.  The Office of Professional and Occupational Licensing will transfer funds from its Licensing and Enforcement program (which includes funds for the Maine Board of Pharmacy) to the Administrative Services Division to fund the allocations.
	The Maine Board of Pharmacy within the Office of Professional and Occupational Licensing has sufficient resources available to support the cost of this legislation without raising fees through the 2022-2023 biennium.   However, fees may need to be increased in future biennia if the current fee structure does not generate sufficient revenue to cover the cost of this legislation.